High sensitivity of ovarian cancer cells to the synthetic triterpenoid CDDO-Imidazolide

Alessia Petronelli, Ernestina Saulle, Luca Pasquini, Eleonora Petrucci, Gualtiero Mariani, Mauro Biffoni, Gianluigi Ferretti, Giovanni Scambia, Pierluigi Benedetti-Panici, Stefano Greggi, Francesco Cognetti, Matteo Antonio Russo, Michael Sporn, Ugo Testa

Research output: Contribution to journalArticle

Abstract

In the present study we have explored the sensitivity of ovarian cancer cells to the synthetic triterpenoid CDDO-Imidazolide (CDDO-Im). For these studies we have used the A2780 ovarian cancer cell line and its chemoresistant derivatives A2780/ADR and A2780/CISP, OVCAR3, SKOV3 and HEY cancer cell lines and primary ovarian cancer cells, providing evidence that: (i) the majority of these cell lines are highly sensitive to the pro-apoptotic effects induced by CDDO-Im; (ii) TRAIL, added alone exerted only a weak proapoptotic, but clearly potentiated the cytotoxic effect elicited by CDDO-Im; (iii) the apoptotic effect induced by CDDO-Im involves GSH depletion, c-FLIP downmodulation and caspase-8 activation; (iv) CDDO-Im inhibits STAT3 activation and CDDO-Im sensitivity is inversely related to the level of constitutive STAT3 activation. Importantly, studies on primary ovarian cancer cells have shown that these cells are sensitive to the pro-apoptotic effects of CDDO-Im. These observations support the experimental use of synthetic triterpenoids in the treatment of ovarian cancer.

Original languageEnglish
Pages (from-to)214-228
Number of pages15
JournalCancer Letters
Volume282
Issue number2
DOIs
Publication statusPublished - Sep 18 2009

Keywords

  • Apoptosis
  • Chemoresistance
  • Ovarian cancer
  • Triterpens

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Fingerprint Dive into the research topics of 'High sensitivity of ovarian cancer cells to the synthetic triterpenoid CDDO-Imidazolide'. Together they form a unique fingerprint.

  • Cite this

    Petronelli, A., Saulle, E., Pasquini, L., Petrucci, E., Mariani, G., Biffoni, M., Ferretti, G., Scambia, G., Benedetti-Panici, P., Greggi, S., Cognetti, F., Russo, M. A., Sporn, M., & Testa, U. (2009). High sensitivity of ovarian cancer cells to the synthetic triterpenoid CDDO-Imidazolide. Cancer Letters, 282(2), 214-228. https://doi.org/10.1016/j.canlet.2009.03.018